Stay Updated
Press Releases
Medicare’s First Negotiated Drug Prices Take Effect: a Win for Patients
Patients on Medicare begin seeing an average list price reduction of 63% percent on the first 10 blockbuster drugs starting January 1st WASHINGTON, D.C. — Today marks a historic milestone for prescription drug affordability in the United States. For the first time in Medicare’s history, lower negotiated prices for 10 of the most expensive and widely used prescription […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs has released the following statement on the retirement of its Founder and President of the Board, David Mitchell. “After 15 years living with cancer and in continuous treatment, David Mitchell is stepping down as President of the Board and retiring from Patients For Affordable Drugs to focus on his health […]
Press Releases
Patients on Medicare will see an average list price reduction of 62% percent on the 15 included drugs. WASHINGTON, D.C. — The Centers for Medicare and Medicaid Services (CMS) has announced the new lower prices from the second round of Medicare drug price negotiations, building on the previous administration’s inaugural first round, and delivering significant savings for patients […]
Press Releases
WASHINGTON, D.C. — Today, the U.S. District Court for the District of Columbia rejected Teva Pharmaceuticals’ challenge to the Medicare Drug Price Negotiation Program — marking the 16th defeat against the industry’s nationwide legal campaign to prevent the law from lowering prices. Teva manufactures Austedo and Austedo XR — used to treat involuntary movements associated […]
Press Releases
Pharma’s Losing Streak In Court Continues: Novo Nordisk’s Appeal Rejected
Bipartisan panel of judges unanimously rejects industry’s recycled arguments as lower drug prices draw closer for millions of patients WASHINGTON, D.C. — In yet another blow to Big Pharma’s nationwide legal campaign against Medicare Negotiation, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novo Nordisk’s challenge to the program this morning — marking the 15th legal defeat for […]
Press Releases
Countering PhRMA’s legal claims, P4AD continues to defend the historic Medicare Negotiation Program by amplifying the experiences of patients with high drug prices. WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed its fifth patient-centered amicus brief defending the Medicare Negotiation Program – this time in the Fifth Circuit Court of Appeals, where PhRMA […]
Press Releases
WASHINGTON, D.C. — AstraZeneca has petitioned the U.S. Supreme Court in a desperate attempt to overturn its 2024 loss in federal court and stop Medicare from negotiating lower drug prices for U.S. patients. The move marks an escalation of pharma’s nationwide legal campaign to preserve the industry’s monopoly pricing power, and would strip President Trump’s […]
Press Releases
Federal Court Rejects Novartis’s Case Against Medicare Negotiation
The unanimous decision marks the 14th ruling against Big Pharma and in favor of patients. WASHINGTON, D.C. — Today, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novartis’ challenge to the Medicare Drug Price Negotiation Program, exactly one week after the same court delivered a similar defeat to Bristol Myers Squibb […]